XML 81 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) A summary of changes in the balances of each component of accumulated other comprehensive loss, net of tax, follows:
 
Defined Benefit Plans
 
Unrealized Losses on Securities
 
Translation Adjustment
 
Total
Balance at January 1, 2017
$
(554
)
 
$
(4
)
 
$
10

 
$
(548
)
Amounts arising during the perioda,b
7

 
1

 
—

 
8

Amounts reclassifiedc
53

 
—

 
—

 
53

Balance at December 31, 2017
(494
)
 
(3
)
 
10

 
(487
)
Adoption of accounting standard for reclassification of income taxes
(79
)
 
—

 
—

 
(79
)
Amounts arising during the perioda,b
(84
)
 
—

 
—

 
(84
)
Amounts reclassifiedc
48

 
3

 
—

 
51

Sale of interest in PT-FI (refer to Note 2)
(6
)
 
—

 
—

 
(6
)
Balance at December 31, 2018
(615
)
 
—

 
10

 
(605
)
Amounts arising during the perioda,b
(118
)
 
—

 
—

 
(118
)
Amounts reclassifiedc
47

 
—

 
—

 
47

Balance at December 31, 2019
$
(686
)
 
$
—

 
$
10

 
$
(676
)
a.
Includes net actuarial gains (losses), net of noncontrolling interest, totaling $52 million for 2017, $(87) million for 2018 and $(111) million for 2019.
b.
Includes tax provision (benefit) totaling $45 million for 2017, $4 million for 2018 and $(8) million for 2019.
c.
Includes amortization primarily related to actuarial losses, net of taxes of $5 million for 2017, and none for 2018
Compensation costs charged against earnings Compensation cost charged against earnings for stock-based awards for the years ended December 31 follows:
 
2019
 
2018
 
2017
 
Selling, general and administrative expenses
$
48

 
$
62

 
$
55

 
Production and delivery
15

 
12

 
16

 
Total stock-based compensation
63

 
74

 
71

 
Tax benefit and noncontrolling interests’ sharea
(4
)
 
(4
)
 
(4
)
 
Impact on net (loss) income
$
59

 
$
70

 
$
67

 

a. Charges in the U.S. are not expected to generate a future tax benefit.
Summary of stock options and SARs outstanding and changes during the period
A summary of stock options outstanding as of December 31, 2019, and activity during the year ended December 31, 2019, follows:
 
Number of
Options
 
Weighted-
Average
Exercise Price
Per Share
 
Weighted-
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic
Value
 
Balance at January 1
46,806,364

 
$
27.40

 

 
 
 
Granted
6,425,500

 
11.88

 
 
 
 
 
Exercised
(391,075
)
 
4.72

 

 
 
 
Expired/Forfeited
(4,528,736
)
 
20.55

 

 
 
 
Balance at December 31
48,312,053

 
26.16

 
4.4
 
$
60

 
 
 
 
 
 
 
 
 
 
Vested and exercisable at December 31
39,981,705

 
28.86

 
3.5
 
$
51

 
Weighted average assumptions used to value stock option awards
Information related to stock options during the years ended December 31 follows:
 
2019
 
2018
 
2017
 
Weighted-average assumptions used to value stock option awards:
 
 
 
 
 
 
Expected volatility
47.8
%
 
46.1
%
 
51.4
%
 
Expected life of options (in years)
6.10

 
5.92

 
5.70

 
Expected dividend rate
1.8
%
 
1.2
%
 
—

 
Risk-free interest rate
2.5
%
 
2.6
%
 
2.0
%
 
Weighted-average grant-date fair value (per option)
$
4.87

 
$
7.84

 
$
7.61

 
Intrinsic value of options exercised
$
3

 
$
7

 
$
5

 
Fair value of options vested
$
26

 
$
24

 
$
25

 
Summary Of Outstanding Stock-settled RSUs and PSUs A summary of outstanding stock-settled RSUs and PSUs as of December 31, 2019, and activity during the year ended December 31, 2019, follows:
 
Number of Awards
 
Weighted-Average Grant-Date Fair Value Per Award
 
Aggregate
Intrinsic
Value
Balance at January 1
5,804,637

 
$
19.97

 
 
Granted
2,135,224

 
11.13

 
 
Vested
(2,191,743
)
 
14.99

 
 
Forfeited
(157,433
)
 
17.58

 
 
Balance at December 31
5,590,685

 
18.61

 
$
73
Summary of Outstanding Cash-Settled RSUs and PSUs A summary of outstanding cash-settled RSUs as of December 31, 2019, and activity during the year ended December 31, 2019, follows:
 
Number of Awards
 
Weighted-Average Grant-Date Fair Value Per Award
 
Aggregate
Intrinsic
Value
Balance at January 1
1,486,866

 
$
15.61

 
 
Granted
819,000

 
11.88

 
 
Vested
(698,817
)
 
13.70

 
 
Forfeited
(24,162
)
 
14.43

 
 
Balance at December 31
1,582,887

 
14.54

 
$
21
Schedule of amounts related to exercises of stock options and stock appreciation rights and the vesting of restricted stock units and restricted stock awards The following table includes amounts related to exercises of stock options and vesting of RSUs during the years ended December 31:
 
2019
 
2018
 
2017
 
FCX shares tendered to pay the exercise price
 
 
 
 
 
 
and/or the minimum required taxesa
670,508

 
195,322

 
1,041,937

 
Cash received from stock option exercises
$
2

 
$
8

 
$
5

 
Actual tax benefit realized for tax deductions
$
1

 
$
3

 
$
1

 
Amounts FCX paid for employee taxes
$
8

 
$
4

 
$
15

 
a.
Under terms of the related plans, upon exercise of stock options, vesting of stock-settled RSUs and payout of PSUs, employees may tender FCX shares to pay the exercise price and/or the minimum required taxes.